← Leaderboards
Ruth Oratz
New York University School Of Medicine
$176,260
Attributed
$176,260
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$176,260 · 3
By mechanism
P30$134,248 · 1
M01$42,012 · 2
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Howard S Hochster$9,390,994
- Franco M Muggia$5,360,861
- Jay Cooper$168,048
- Mark Reid Philips$38,261,818
- Roman Perez-Soler$12,753,063
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchDrug Screening /EvaluationCombination Cancer TherapyHuman Therapy EvaluationHuman SubjectNeoplasm /Cancer ChemotherapyMelanomaHistamineQuality Of LifeBiopsyBryostatinCis Platinum CompoundClinical Trial Phase IDosageEnzyme ActivityInterleukin 2Neoplasm /Cancer ImmunotherapyOncogenesPharmacokineticsProtein Kinase CNeoplasm /CancerCancer Registry /ResourceNeoplasm /Cancer EducationPatient Care Management
Grant awards (9)
INTERLEUKIN 2 + HISTAMINE VERSUS INTERLEUKIN 2 IN ADVANCE MALIGNANT MELANOMA$0
M01 · FY2002 · RR
BRYOSTATIN 1 (NSC339555) &CISPLATIN IN ADVANCED MALIGNANCIES$0
M01 · FY2002 · RR
BRYOSTATIN 1 (NSC339555) &CISPLATIN IN ADVANCED MALIGNANCIES$0
M01 · FY2001 · RR
INTERLEUKIN 2 + HISTAMINE VERSUS INTERLEUKIN 2 IN ADVANCE MALIGNANT MELANOMA$0
M01 · FY2001 · RR
CORE--CLINICAL RESEARCH RESOURCES$134,248
P30 · FY2000 · CA
INTERLEUKIN 2 + HISTAMINE VERSUS INTERLEUKIN 2 IN ADVANCE MALIGNANT MELANOMA$21,006
M01 · FY2000 · RR
BRYOSTATIN 1 (NSC339555) &CISPLATIN IN ADVANCED MALIGNANCIES$21,006
M01 · FY2000 · RR
INTERLEUKIN 2 + HISTAMINE VERSUS INTERLEUKIN 2 IN ADVANCE MALIGNANT MELANOMA$0
M01 · FY2000 · RR
BRYOSTATIN 1 (NSC339555) &CISPLATIN IN ADVANCED MALIGNANCIES$0
M01 · FY2000 · RR